Get started
Author

Lisa Lohmann

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
2023 · Tania Kümpfel, Katrin Giglhuber, et al. · Journal of Neurology · 259
PDF
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD
2023 · Ankelien Duchow, Judith Bellmann‐Strobl, et al. · Annals of Neurology · 72
PDF
Classification of neurological diseases using multi-dimensional CSF analysis
2021 · Catharina C Gross, Andreas Schulte-Mecklenbeck, et al. · Brain · 65
PDF
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis
2021 · Melanie Eschborn, Marc Pawlitzki, et al. · Neurology Neuroimmunology & Neuroinflammation · 54
PDF
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories
2024 · Catharina C. Gross, Catharina C. Gross, et al. · Science Translational Medicine · 52
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
2024 · Marius Ringelstein, Susanna Asseyer, et al. · Neurology · 37
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD
2024 · Vivien Häußler, Corinna Trebst, et al. · Journal of Neurology Neurosurgery & Psychiatry · 31
PDF
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid—Results from the ToFingo Successor Study
2018 · Lisa Lohmann, Claudia Janoschka, et al. · Frontiers in Immunology · 28
PDF
Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis
2020 · Michael Heming, Lisa Lohmann, et al. · Journal of Neuroimmunology · 25
PDF
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
2024 · Tania Kümpfel, Katrin Giglhuber, et al. · Journal of Neurology · 14
PDF
Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report
2022 · Lisa Lohmann, Felix Glaser, et al. · BMC Neurology · 11
PDF
Impact of disease‐modifying therapies on humoral and cellular immune‐responses following SARS‐CoV‐2 vaccination in MS patients
2022 · Susan Trümpelmann, Andreas Schulte‐Mecklenbeck, et al. · Clinical and Translational Science · 9
PDF
An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD
2019 · Julius Obergassel, Lisa Lohmann, et al. · Prion · 8
PDF
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision
2024 · Mihaela Nicolescu, Vivien Häußler, et al. · Journal of Neurology · 5
Status of clinical research in neurology in Germany—A national survey
2021 · Lisa Lohmann, Anna Lammerskitten, et al. · European Journal of Neurology · 5
PDF
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders
2026 · Daria Tkachenko, Ilya Ayzenberg, et al. · Neurological Research and Practice · 1
PDF
Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges (P13-5.017)
2023 · Ilya Ayzenberg, Susanna Asseyer, et al. · Neurology · 1
Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories (P1-3.008)
2023 · Catharina C. Gross, Andreas Schulte-Mecklenbeck, et al. · Neurology
Signatures of premature immunosenescence in patients with multiple sclerosis (P1-1.Virtual)
2022 · Melanie Eschborn, Marc Pawlitzki, et al. · Neurology
Epstein-Barr-Virus – Neue Daten zur Rolle als Risikofaktor für Multiple Sklerose
2022 · Lisa Lohmann · DGNeurologie
PDF
Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen
2021 · Lisa Lohmann, Luisa Klotz, et al. · Fortschritte der Neurologie · Psychiatrie
Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen
2021 · Lisa Lohmann, Luisa Klotz, et al. · Neuroradiologie Scan
Therapie der Multiplen Sklerose - Wie relevant ist das Alter?
2021 · Lisa Lohmann · DGNeurologie
Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen
2020 · Lisa Lohmann, Luisa Klotz, et al. · Neurologie up2date
Erratum zu: Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen
2020 · Lisa Lohmann, Luisa Klotz, et al. · Neurologie up2date
Works count: 28
Citation count: 677
H-index: 11
I10-index: 11
Year
Topic
Type